Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
Open Access
- 7 May 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (17), 1864-1882
- https://doi.org/10.3748/wjg.v27.i17.1864
Abstract
With the growing prevalence of obesity and diabetes in the United States and across the world, a rise in the overall incidence and prevalence of non-alcoholic fatty liver disease (NAFLD) is expected. The risk factors for NAFLD are also associated with the development of chronic kidney disease (CKD). We review the epidemiology, risk factors, genetics, implications of gut dysbiosis, and specific pathogenic mechanisms linking NAFLD to CKD. Mechanisms such as ectopic lipid accumulation, cellular signaling abnormalities, and the interplay between fructose consumption and uric acid accumulation have led to the emergence of potential therapeutic implications for this patient population. Transplant evaluation in the setting of both NAFLD and CKD is also reviewed. Potential strategies for surveillance and management include the monitoring of comorbidities, the use of non-invasive fibrosis scoring systems, and the measurement of laboratory markers. Lastly, we discuss the management of patients with NAFLD and CKD, from preventative measures to experimental interventions.Keywords
This publication has 144 references indexed in Scilit:
- Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosisJournal of Hepatology, 2013
- Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty LiverPLOS ONE, 2012
- Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic SteatohepatitisClinical Journal of the American Society of Nephrology, 2010
- Regulation of podocyte survival and endoplasmic reticulum stress by fatty acidsAmerican Journal of Physiology-Renal Physiology, 2010
- p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney diseaseNephrology Dialysis Transplantation, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisThe New England Journal of Medicine, 2010
- A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin ResistanceScience, 2008
- Proteinuria and Hyperglycemia Induce Endoplasmic Reticulum StressJournal of the American Society of Nephrology, 2008
- What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?Diabetologia, 2008
- Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2008